Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,436,550
-$2,900,270 QoQ
Shares Held
6,998
-19.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $77,931,464 across 17 Drug Manufacturers - General names. LLY ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
303,856 | $36,550,838 | |
| 2 | ABBV |
AbbVie Inc.
|
48,857 | $10,625,908 | |
| 3 | JNJ |
Johnson & Johnson
|
41,381 | $10,115,171 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
6,998 | $6,436,550 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
73,108 | $4,434,000 | |
| 6 | PFE |
Pfizer Inc
|
79,856 | $2,242,356 | |
| 7 | AMGN |
Amgen Inc
|
5,229 | $1,839,823 | |
| 8 | AZN |
Astrazeneca PLC
|
6,722 | $1,325,712 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,436,550 | 6,998 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,336,820 | 8,688 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,215,569 | 22,563 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,365,873 | 3,035 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,037,519 | 2,467 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,063,556 | 2,673 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,183,841 | 2,465 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,215,464 | 2,447 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,518,577 | 1,952 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,164,091 | 1,997 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,154,829 | 2,150 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,024,252 | 2,184 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $747,281 | 2,176 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $760,581 | 2,079 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $633,766 | 1,960 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $812,196 | 2,505 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $462,487 | 1,615 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $441,123 | 1,597 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $368,293 | 1,594 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $355,067 | 1,547 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $258,662 | 1,532 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $226,174 | 1,528 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $234,613 | 1,429 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $197,676 | 1,425 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||